2024 IART Annual Conference: The Core of Regenerative Medicine Treatment of Musculoskeletal Pain
About the Course
The IART conference has invited renowned faculty to give presentations and participate in a panel to give answers to tough questions about prolotherapy, PIT, regenerative injections, and the use of ultrasound prolotherapy techniques.
Elements of Competence
This CE activity has been designed to change learner competence and focuses on the following competencies:
American Board of Medical Specialties:
- patient care and procedural skills
- medical knowledge
- practice-based learning and improvement.
Statement of Need
The treatment of chronic pain is a complex, multifaceted problem. The faculty of this activity offer participants detailed instruction in the use of prolotherapy to treat laxity of ligaments that often cause chronic myofascial pain. Due to more active lifestyles, an aging patient population, and patient desire for relief of chronic pain, prolotherapy is an elegant, effective and safe treatment.
Intended Audience
This educational activity has been designed to meet the needs of physicians, (MD and DO) and other healthcare providers (nurses, naturopaths and physician assistants) who provide pain management services for musculoskeletal pain.
Learning Objectives
At the conclusion of this activity, participants, as members of the healthcare team, will be able to:
- Analyze anatomy of the musculoskeletal system
- Summarize non-surgical treatment options for orthopedic and neurogenic pain.
- Discuss injection techniques for orthopedic and neuropathic pain.
Day 1: Wednesday, September 18, 2024: PERNEURAL INJECTION THERAPY AND HYDRODISSECTION TECHNIQUES | |
AM Sessions | |
7:45-8:00 AM | Pre-Conference Welcome & Administrative Remarks: Annette Zaharoff, MD |
8:00-8:45 AM | Perineural Injection Treatment and the Evolving Science of Dextrose Nerve Blocks: An Update, Liza Maniquis-Smigel, MD |
8:45-9:15 AM | Pre and Post Care Instructions for Perineural Injection Treatments, Liza Maniquis-Smigel, MD |
9:15-10:15 AM | Nerve Anatomy of the Low Back and Gluteal and Hip Region, Liza Maniquis-Smigel, MD |
10:15-10:30 AM | PIT Marking for Low Back and Hip Region LIza Maniquis-Smigel, MD & Joel Baumgartner, MD |
10:30-10:45 AM | Live Patient PIT Treatment for Low Back or Hip Region (Eric Phillipi, MD) |
10:45-11:00 AM | Break and Exhibits |
11:00-11:45 | Nerve Anatomy Around the Knee and Ankle Region, Meleine Ongchuan, MD |
11:45-AM 12:15 PM | Live Patient PIT Demonstrations, Pain of Knee, Ankle and Foot Region Eric Phillippi, MD |
PM Sessions | |
12:15-1:00 PM | Lunch & Exhibits |
1:00-1:45 PM | Ultrasound of the Entrapment Neuropathies of the Low Back and Hip Region, Joel Baumgartner, MD |
1:45-2:15 PM | Ultrasound Scanning Demonstration of Nerves of Low Back and Hip (3 Stations) |
2:15-2:30 PM | Break & Exhibits |
2:30-3:00 PM | Ultrasound of the Entrapment Neuropathies of the Knee, Ankle and Foot Region, Jeimylo Decastro, MD |
3:00-3:30 PM | Ultrasound Scanning Demonstration of Nerves of the Knee, Ankle and Foot Region (3 stations) |
3:30-5:15 PM | Q&A and Closing Remarks, Annette Zaharoff, MD |
Day 2: Thursday, September 19, 2024: ADVANCED SESSION: A DEEP DIVE INTO NERVES FROM CRANIUM TO THORACIC OUTLET *Day 2 and Day 3 will include THREE (3) different Workshop Sessions, each lasting 3 Hours: Palpation/Marking Session, Cadaver Session, U/S Session. Each attendee will rotate through each session. Attendees will be assigned to a GROUP and will stay in that assigned group throughout the entire workshop section. | |
AM Sessions | |
7:50-8:00 AM | Opening Remarks: Annette-Zaharoff, MD. |
8:00-9:00 AM | Normal Anatomy, U/S Scanning Technique and Pathology of the Cranial Nerves, Cervical Plexus, and Cervical Nerve Roots, Jeff Strakowski, MD |
9:00-10:00 AM | Live Demonstration and Hands-On Workshop of the Cranial Nerves, Cervical Plexus, and Cervical Nerve Roots, Jeff Strakowski, MD |
10:00-10:15 AM | Break & Exhibits |
10:15-11:15 AM | Normal Anatomy, U/S Scanning Technique and Pathology of the Brachial Plexus and Thoracic Outlet, Jeff Strakowski, MD |
11:15-11:50 AM | Live U/S Scanning and Hands-On Workshop of Brachial Plexus and Thoracic Outlet, Jeff Strakowski, MD |
11:50-12:00 PM | Q&A and Closing Remarks Eric Phillippi, MD |
PM Sessions | |
12:00-1:30 PM | Lunch & Exhibits |
1:30-2:00 PM | Prolotherapy Pearls Adrian Gretton, MD |
Workshop Orientation* (All Groups) *Day 2 and Day 3 will include THREE (3) different Workshop Sessions, each lasting 3 Hours: Palpation/Marking Session, Cadaver Session, U/S Session. Each attendee will rotate through each session. Attendees will be assigned to a GROUP and will stay in that assigned group throughout the entire workshop section. | |
2:00-3:30 PM | Workshop Session 1: Group #1: Palpation/Marking Session Group #2: Cadaver Session Group #3: U/S Session |
3:30-4:00 PM | Break & Exhibits |
4:30-5:30 PM | Workshop Session 2: Group #1: Palpation/Marking Session Group #2: Cadaver Session Group #3: U/S Session |
6:30-9:00 PM | IART Banquet |
Day 3: Friday, September 20, 2024: HANDS-ON WORKSHOPS *Day 2 and Day 3 will include THREE (3) different Workshop Sessions, each lasting 3 Hours: Palpation/Marking Session, Cadaver Session, U/S Session. Each attendee will rotate through each session. Attendees will be assigned to a GROUP and will stay in that assigned group throughout the entire workshop section. | |
AM Sessions | |
7:45-8:30 AM | Welcome: Annette Zaharoff, MD |
8:00-8:30 AM | The Application of Biotensegrity in MSK Medicine - Gary Clark, MD |
8:30-9:00 AM | Injection Safety: David De la Mora, MD |
9:00-10:30 AM | Workshop Session 2 Group #1: Palpation/Marking Session Group #2: Cadaver Session Group #3: U/S Session |
10:30-11:00 AM | Break & Exhibits |
11:00-12:30 PM | Workshop Session 2 Group #3: Palpation/Marking Session Group #1: Cadaver Session Group #2: U/S Session |
12:30-1:30 PM | Lunch & Exhibits |
PM Sessions | |
1:30-3:00 PM | Workshop Session 3: Group #2: Palpation/Marking Session Group #3: Cadaver Session Group #1: U/S Session |
3:00-3:30 PM | Break & Exhibits |
3:30-5:00 PM | Workshop Session 3: Group #2: Palpation/Marking Session Group #3: Cadaver Session Group #1: U/S Session |
Day 4: Saturday, September 21, 2024 | |
7:45-8:00 AM | Welcome: Annette Zaharoff, MD |
8:00-8:30 AM | Challenging the Dogma of Hypertonic, Inflammatory, Dextrose (D-glucose), Prolotherapy,: An in-vivo study, Dean Reeves, MD |
8:30:9:00 AM | Prolotherapy and Research Topic: Assessing the Strength of Evidence David Rabago, MD |
9:00-9:30 AM | Mechanisms of the Neuromodulatory Effect of Dextrose, Aeneas Janze, MD |
9:30-10:00 AM | Break & Exhibits |
10:00-10:30 AM | Ultrasound Assisted Prolotherapy of the Low Back, Brian Shiple, DO |
10:30-11:00 AM | Lifestyle Medicine - Martin Gallagher, MD, DC |
11:00-11:30 AM | Regenerate the Power of Macrophage Polarization - Maximize Regeneration and Minimize Pain through Macrophage Polarization: Joel Baumgartner, MD |
11:30-12:30 PM | Q&A Session |
12:30-12:45 PM | Conclusion |
Please see the Program for further information.
A link will be sent to virtual participants prior to the activity start date.
Program Changes
Emergency situations occasionally occur and may necessitate topic or speaker change. The IART, HHPF, and University of Wisconsin–Madison ICEP reserves the right to alter or substitute a topic or speaker without prior notification.
Planning Committee
Adrian Gretton, MD, CCFP, FCFP, CIME, Momentum Health, Evidence Sports & Spine
Mandy Engels, Planner, The Rees Group, Inc
Kristen Lucas, MS, Planner, Office of Continuing Professional Development, University of Wisconsin School of Medicine & Public Health
Brooke Miller, CMP, VEMM, Planner, Director of Meetings, The Rees Group, Inc.
James Nosal, MD, Forest County Potawatomi Health and Wellness Center
Liza Maniquis-Smigel, MD, Hawaii Center for Regenerative Medicine
David Wang, DO, ROSM, Regenerative Orthopedics and Sports Medicine
Michael Weber, MD, Clinical Assistant Professor, Department of Family Medicine & Community Health, University of Wisconsin School of Medicine and Public Health
Annette Zaharoff, MD, The Non-Surgical Center of Texas
Faculty
Joel Baumgartner, MD; Rejuv Medical
John Broussard, MD, Alliance Regen and Rehabilitation
Gary Clark, MD, Boulder Prolotherapy
Tricia Croake-Uleman, MD, Southwest Ohio Health Partners and Regenerative Medicine
Jeimylo De Castro, MD, FPARM, RMSK, Philippine Academy of Rehabilitation Medicine
David De La Mora, MD, Director, HHPF Guadalajara Chapter
Martin Gallagher, MD, DC, ABOIM, Medical Wellness Associates
Adrian Gretton, MD, CCFP, FCFP, CIME, Momentum Health, Evidence Sports & Spine
Jay Harms, MD, Unity Point Clinic
Greg Hon, MD, Campbell University School of Osteopathic Medicine
Aeneas Janze, MD, US Army - Walter Reed National Military Medical Center
Andrew Kochan, MD, Kochan Pain Treatment Center
James Nosal, MD, Forest County Potawatomi Health and Wellness Center
Bobby Nourani, DO, Private Practice - Dr. Nourani
Meleine Ongchuan, MD, DPBRM, FPARM, Philippine Academy of Rehabilitation Medicine
Ripal Parikh, DO, Regen Medical, Inc.
Eric Phillippi, MD, Medical Procedures of Wisconsin
David Rabago, MD, Penn State Health; Department of Family and Community Health
Brian Ralston, MD, MacNeal Family Medicine Residency
Dean Reeves, MD, Prolotherapy of Kansas City
Brian Shiple, DO, The Center for Sports Medicine
Liza Maniquis-Smigel, MD, Hawaii Center for Regenerative Medicine
Jeff Strakowski, MD, Ohio Health Grant Medical Center
Linh Vuong, MD, Acuprolo Institute
Tinh Vuong, DO, Acuprolo Institute
David Wang, DO, Regenerative Orthopedics and Sports Medicine
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
NAME | ROLE(S) | FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
Joel Baumgartner, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
John Broussard, DO | Faculty | No relevant relationships with ineligible companies to disclose. | No |
Gary Clark, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose. | No |
Tricia Croake, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Jeimylo De Castro, MD, FPARM, RMSK | Speaker/Author | No relevant relationships with ineligible companies to disclose | Yes |
David De La Mora, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Mandy Engels | Planner | No relevant relationships with ineligible companies to disclose | No |
Martin Gallagher, MD, DC, ABOIM | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Adrian Gretton, MD,CCFP, FCFP, CIME | Committee Member/Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Jay Harms, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Greg Hon, MD | Faculty | No relevant relationships with ineligible companies to disclose. | No |
Aeneas Janze, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Andrew Kochan, MD | Faculty | No relevant relationships with ineligible companies to disclose. | No |
Kristen Lucas | Planner | No relevant relationships with ineligible companies to disclose | No |
Brooke Miller | Planner | No relevant relationships with ineligible companies to disclose | No |
James Nosal, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Bobby Nourani, DO | Faculty | Slanted Adapter, LLC | No |
Meleine Ongchuan, MD, DPBRM, FPARM | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Ripal Parikh, DO | Faculty | No relevant relationships with ineligible companies to disclose. | No |
Eric Phillippi, MD | Faculty | No relevant relationships with ineligible companies to disclose. | No |
David Rabago, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Brian Ralston, MD | Faculty | No relevant relationships with ineligible companies to disclose | No |
Dean Reeves, MD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Brian Shiple, DO | Speaker/Author | GoodBiologics, LLC | Yes |
Liza Maniquis-Smigel, MD | Committee Member/Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Jeff Strakowski, MD | Speaker/Author | Gulf Coast Ultrasound, Natus and Cadwell, Demos Medical/Springer | Yes |
Linh Vuong, MD | Faculty | No relevant relationships with ineligible companies to disclose. | Yes |
Tinh Vuong, DO | Faculty | No relevant relationships with ineligible companies to disclose. | No |
David Wang, DO | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Michael Weber, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Annette Zaharoff, MD | Committee Chair/Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP), International Association of Regenerative Therapy (IART). The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin-Madison, as a member of the University Continuing Education Association (UCEA) authorizes this program for 2.60 continuing education units (CEUs) or 26.0 hours.
Available Credit
- 26.00 AMA PRA Category 1 Credit™
- 26.00 University of Wisconsin–Madison Continuing Education Hours
- 26.00 Approved for AMA PRA Category 1 Credit™
Program Changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at [email protected]
For Further Information
For conference information please contact Kristen Lucas [email protected].
Required Hardware/software
Virtual attendees: laptop, desktop, or tablet with video streaming capability.